Sign Up Today and Learn More About Paradromics Stock
Invest in or calculate the value of your shares in Paradromics or other pre-IPO companies through EquityZen's platform.
Paradromics Stock (PARR)
Paradromics is developing high data rate brain computer interfacing technology
About Paradromics Stock
Founded
2015
Headquarters
Austin, TX, US
Industries
Software, Artificial Intelligence, Data and Analytics
Paradromics Press Mentions
Stay in the know about the latest news on Paradromics
Methods for improved biocompatibility for human implanted medical devices
patents • Apr 02, 2025
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market
globenewswire • Apr 01, 2025
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market
marketscreener • Apr 01, 2025
Brain Computer Interface Market CAGR to be at 7.80% By 2032 | Bridging Human Minds and Machines
einpresswire • Mar 17, 2025
Financings for Feb. 14, 2025
bioworld • Feb 15, 2025
Paradromics Management
Leadership team at Paradromics
CEO
Matt Angle
Board Member
Amy Kruse
Join now and verify your accreditation status to gain access to:
- Paradromics Current Valuation
- Paradromics Stock Price
- Paradromics Management
- Available deals in Paradromics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Paradromics Cap Table and Funding History by Share Class and Liquidity Preferences
- Paradromics Revenue and Financials
- Paradromics Highlights
- Paradromics Business Model
- Paradromics Risk Factors
- Paradromics Research Report from SACRA Research
Trading Paradromics Stock
How to invest in Paradromics stock?
Accredited investors can buy pre-IPO stock in companies like Paradromics through EquityZen funds. These investments are made available by existing Paradromics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Paradromics stock?
Shareholders can sell their Paradromics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
